These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1417 related items for PubMed ID: 8282068

  • 21. Glatiramer acetate could be a potential therapeutic agent for Parkinson's disease through its neuroprotective and anti-inflammatory effects.
    Tsai SJ.
    Med Hypotheses; 2007; 69(6):1219-21. PubMed ID: 17548170
    [Abstract] [Full Text] [Related]

  • 22. Oestrogen and nigrostriatal dopaminergic neurodegeneration: animal models and clinical reports of Parkinson's disease.
    Liu B, Dluzen DE.
    Clin Exp Pharmacol Physiol; 2007 Jul; 34(7):555-65. PubMed ID: 17581209
    [Abstract] [Full Text] [Related]

  • 23. [Neurotrophins. II: therapeutic potential].
    Zazpe A, Del Río J.
    Rev Med Univ Navarra; 1997 Jul; 41(3):180-4. PubMed ID: 10420924
    [Abstract] [Full Text] [Related]

  • 24. Heredity in Parkinson's disease: new findings.
    Lev N, Melamed E.
    Isr Med Assoc J; 2001 Jun; 3(6):435-8. PubMed ID: 11433638
    [Abstract] [Full Text] [Related]

  • 25. Oxidative mechanisms in nigral cell death in Parkinson's disease.
    Jenner P.
    Mov Disord; 1998 Jun; 13 Suppl 1():24-34. PubMed ID: 9613715
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Minor retinal degeneration in Parkinson's disease.
    Huang YM, Yin ZQ.
    Med Hypotheses; 2011 Feb; 76(2):194-6. PubMed ID: 20933338
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Parkinson's disease.
    Wolters EC, Calne DB.
    CMAJ; 1989 Mar 01; 140(5):507-14. PubMed ID: 2563667
    [Abstract] [Full Text] [Related]

  • 32. [The life history of brain dopamine].
    Hornykiewicz O.
    Wien Klin Wochenschr; 1985 Apr 12; 97(8):350-4. PubMed ID: 2986364
    [Abstract] [Full Text] [Related]

  • 33. Treatment of Parkinson's disease.
    Aminoff MJ.
    West J Med; 1994 Sep 12; 161(3):303-8. PubMed ID: 7975571
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Plasticity of nerve afferents to nigrostriatal neurons in Parkinson's disease.
    Anglade P, Tsuji S, Javoy-Agid F, Agid Y, Hirsch EC.
    Ann Neurol; 1995 Feb 12; 37(2):265-72. PubMed ID: 7847868
    [Abstract] [Full Text] [Related]

  • 36. Parkinson's disease.
    Béné R, Antić S, Budisić M, Lisak M, Trkanjec Z, Demarin V, Podobnik-Sarkanji S.
    Acta Clin Croat; 2009 Sep 12; 48(3):377-80. PubMed ID: 20055267
    [Abstract] [Full Text] [Related]

  • 37. Brain neurotransmitters and neuropeptides in Parkinson's disease.
    Rinne UK, Rinne JO, Rinne JK, Laakso K, Lönnberg P.
    Acta Physiol Pharmacol Latinoam; 1984 Sep 12; 34(3):287-99. PubMed ID: 6099688
    [Abstract] [Full Text] [Related]

  • 38. Novel CDNF/MANF family of neurotrophic factors.
    Lindholm P, Saarma M.
    Dev Neurobiol; 2010 Apr 12; 70(5):360-71. PubMed ID: 20186704
    [Abstract] [Full Text] [Related]

  • 39. The nigrostriatal system in Parkinson's disease.
    Graybiel AM, Hirsch EC, Agid Y.
    Adv Neurol; 1990 Apr 12; 53():17-29. PubMed ID: 1978514
    [Abstract] [Full Text] [Related]

  • 40. Future perfect? Presymptomatic diagnosis, neural transplantation, and trophic factors.
    Shults CW.
    Neurol Clin; 1992 May 12; 10(2):567-93. PubMed ID: 1584189
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 71.